Life long Maverick: Seen it ALLl in 40 yrs of PROF. exposure as invest analyst/port mgr on the FRONT lines vs iHub Msg Bds.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NWBO worth much MORE to MERCK (IMHO) than this just announced $10.8 Bln in cash to acquire Prometheus Biosciences a greater than 20 year old company(RXDX):
https://ir.prometheusbiosciences.com/news-releases/news-release-details/merck-strengthens-immunology-pipeline-acquisition-prometheus/
1)RXDX is in a much smaller market (Int Bowel Disease) than NWBO’s CANCER (Solid Tumors so is worth much MORE)
2)RXDX in PH2 vs COMPLETED PH3 DCVAX L for nGBM & Peer Reviewed before Elite published Nov ‘22 JAMA Oncology Review (Multiple Times that of a PH2)
3)Unknown whether RXDX had MFG scalability for approvability: but MRK will resolve.
RXDX pipeline https://t.co/MQ5LtdhC3A
RXDX INSTL ownership exceeds 80% courtesy of 2021 IPO thru
1)Chrman/CEO McKenna who worked @ Bausch& Lomb! (& other Bd members re Priv Equity EW Warburg run by Ken Geithner former NYFed Res 2008! … that owns Bausch & Lomb)
2) Bd member Fred Hassan was CEO of Schering Plough! bought by MERCK
Monday MRK 8 am Conf Call: https://t.co/IQpK1P9a4K
In early Dec 2022 NWBO filed a Federal Lawsuit for Illegal Spoofing that since 2017 it’s share prices have been manipulated by 7 FINANCIAL TITAN Market Makers (ie Citadel! ETC). The case was taken on by Laura Posen of Cohen Milstein. They will only be paid if they win: Contingency Fee basis. Laura Posen has won many cases for Institutional Investors and has a working relationship & track record with both the SEC and Dept of Justice.
One PRIME Example on Friday of RIGGED Markets:
Take a look at CNSP
2 mln shs outstanding
Traded 50 MILLION!!!
Friday Low 67 cts … now $3.36
1:26p ET 4/14/2023 - Benzinga
*Shares of low-float CNS Pharmaceuticals are trading higher. Not seeing any company-specific news to justify the price action.
Mentioned: CNSP
So all the NWBO hecklers naysayers : achieves nothing: only selling does.
Rarely if ever are there LINKS to support their vents and they do not understand WHY + little demonstrated credibility(some for 8+ years in NWBO or other emerging biotech stocks) , lacking credentials are in IMHO venting like insurrectionists.
They fail to understand ALL the many multi lateral strictures or market forces that ARE present that NWBO CEO Linda Powers faces since 2015!
Buy Diamond in the Rough, wrongfully maligned by DARK FORCES in this social media era for $ vs extending & saving lives NWBO Ph 3! that HAS BEEN UNDER THE HEEL of SHORTS, NAKED SHORTS, EVEN RIGGED MKTS and FORCED into clandestine silence along with dealing with FOUR REGULATORY AGENCIES & their labyrinth of communication protocols since 2015
For last 4 years only allowed ONE NWBO post daily for INFINITY.
The growing, intelligent SWAT team over the last 18 months will continue to overcome NONSENSE.
In this truly EPIC Saga, short posts amount to SQUAT Period.
An award winning movie producer is already lined up!
From THRICE near ASHES to THE PHOENIX thru 4 FEMALE PHENOMENONS
DIFFERENT STROKES for DIFFERENT FOLKS
Shares DOWN on BIG Volume due to 2 days of NONSENSE since Larry Smith update
caused by King of NOTHNG needing attention, belaboring & nitpicking minutiae!
AND DARK Forces POUNCE by front running any size seller on ASk & Small volume on BID side heightening seller concern’s : HOW DO I SELL WITHOUT IT CAVING IN!
NOT for THE GREATER GOOD PERIOD.
Destructive for ALL except those to BUY (It HELPS SHORT SELLERS COVER!: AIDING the ENEMY!
Some people are NEVER ACCOUNTABLE for YEARS of DAMAGE making CEO Linda Powers ALBATROSS heavier since 2015
DIFFERENT STROKES for DIFFERENT FOLKS
How CEO Linda Powers ROLLS.. UNLIKE otherS:
These Drugs Are So Futuristic That Doctors Need New Training -- WSJ
By Amy Dockser Marcus for The Wall Street Journal
A major obstacle looms for the drugs of the future. Not enough doctors know how to administer them.
For just one rare neurodevelopmental disorder, known as Angelman syndrome, clinical trials are testing four cutting-edge therapies. Twenty more research programs are under way and could yield treatments ready to move into human testing in the next several years, according to Allyson Berent-Weisse, chief scientific officer of the Foundation for Angelman Syndrome Therapeutics, or FAST, and the mother of a child with the disorder.
These promising therapies include antisense oligonucleotides (or ASOs) which affect how proteins inside cells are made; Crispr gene editors that can cut, rewrite, or replace faulty genes; and other novel approaches.
But there's a hitch. Some of these drugs, as well as therapies in development for other conditions, are administered through lumbar punctures, which aren't a routine part of doctors' daily practices. They may involve infusions of a gene packaged inside the shell of a virus, which can lead to potential immune complications and can require close monitoring of patients. Some drugs need to be stored in special conditions, which can take complicated planning and coordination that few doctors have experienced.
"The bottleneck used to be the science and finding drugs," says Dr. Berent-Weisse. "The new bottleneck is having enough people trained to give them."
That's bringing new efforts to address the problem.
Kite, owned by Gilead Sciences Inc., runs a qualification program that takes around six months for doctors and centers interested in administering the company's CAR T-cell cancer therapy, Yescarta. The therapy, which received Food and Drug Administration approval last year for second-line treatment of adults with a type of lymphoma, involves re-engineering patients' cells and must be stored at minus 150 degrees Celsius (minus 238 degrees Fahrenheit) until it is ready to be used. If the re-engineered cells don't stay frozen during transport and if they aren't thawed in water whose temperature is constantly monitored to remain "not too hot and not too cold" -- called the "water bath" method -- the therapy can't be infused into the patient, says Deidre Hobbs, vice president of quality at Kite.
"We have groundbreaking science that can change the lives of hematology patients, but if we can't get it to these patients, the science is lost, " says Warner Biddle, ad interim head of Kite and global head of commercial.
Spark Therapeutics Inc., a member of the Roche Group and maker of a gene therapy called Luxturna, which the FDA approved in 2017 to treat an inherited retinal disease that can lead to blindness, designated special centers where retinal surgeons receive instruction manuals and hands-on training in how to give the treatment. The surgeons must administer Luxturna through a single injection into the back of each eye, under the retina. "Given the one-time nature of gene therapy, Spark is committed to providing the resources necessary to deliver safe and effective treatment to patients," a company spokesperson said.
FAST, set up in 2008 by parents hoping to hoping to find a cure for Angelman syndrome, which affects children and adults, is providing $5 million to establish a center at Rush University Medical Center in Chicago, Ill., where doctors will receive training on how to run clinical trials and deliver therapies. The disease, caused by the loss of a functioning copy of the gene UBE3A that makes an important protein in the neurons, leaves patients unable to speak and can cause seizures and severe sleep disturbance.
The techniques will apply to other neurodevelopmental disorders, which often use similar treatments. After a year of practice and hands-on experience, the doctors can go back to their own centers and train others, says Alana Newhouse, FAST's president and the mother of a son with Angelman syndrome. Additional money is available for doctors interested in pursuing shorter stints at Rush in order to get practical experience with administering cutting-edge medications, Ms. Newhouse says.
The training program will be run by Elizabeth Berry-Kravis, a pediatric neurologist at Rush University who will also serve as the director of the new center, called the Rush Pediatric Neurosciences F.A.S.T Center for Translational Research. Dr. Berry-Kravis is administering novel therapies to patients with neurological disorders including Angelman syndrome, fragile X syndrome, Batten disease, Niemann-Pick disease Type C, and others.
"Doctors are trained to see patients in the clinic. They are not trained in how to open a trial or how to navigate a contract or how to deliver drugs through intrathecal procedures," says Dr. Berry-Kravis. "We will train them. The doctors will get those skills. They will be ready to go out and mimic what we are doing."
Many doctors recognize that delivering cutting-edge drugs to patients isn't only a science but also an art, she says. "There are little techniques involved when giving infusions." When inserting the needle for an infusion into a patient's lower back, direct it toward the brain, for instance. Put patients head-down to let gravity help pull the drug to the brain, she adds, or in some cases use larger volumes in order to push more drug to the brain.
Hospitals often don't have enough space and support staff to rapidly enroll people, or doctors and specialists to administer the drugs, says Dr. Berent-Weisse, who helped devise the idea for a training program based on her own experiences and after speaking with doctors about some of the obstacles they were facing in enrolling patients.
One of the trials already under way at Rush for Angelman syndrome involves GTX-102, an ASO therapy being developed by Ultragenyx Pharmaceutical Inc. Dr. Berent-Weisse is a paid consultant to Ultragenyx.
Emil Kakkis, the CEO of Ultragenyx, says the company has struggled to find enough sites that have doctors and specialists, like pharmacists and anesthesiologists, who know how to open trials and prepare and administer GTX-102. "It is smart to set up training now so there will be a society of doctors in the future who can someday use these drugs," said Dr. Kakkis.
FAST is also considering opening a training center at Yale School of Medicine. As part of that effort, Yale will send someone to take part in the inaugural program at Rush, according to Yong-Hui Jiang, chief of medical genetics and a professor at Yale School of Medicine. Rush hopes to kick off the training program later this year.
Dr. Jiang, a specialist in the evaluation and treatment of neurodevelopmental disorders such as Angelman syndrome, says many families come to see him for a diagnosis -- and ask about potential treatments after they receive it.
In his own lab, Dr. Jiang is working on Crispr gene-editing therapies that he hopes will someday be available for Angelman patients and to treat other rare conditions as well. He and some colleagues founded a company, Couragene, and hope to eventually sponsor a Crispr trial.
Exciting new treatments are ahead, Dr. Jiang tells the families who seek his help. When it comes to delivering them, he acknowledges, "We are all learning together right now."
https://www.wsj.com/articles/these-drugs-are-so-futuristic-that-doctors-need-new-training-d88c10dc
From THRICE near ASHES to THE PHOENIX
The Market has been RIGGED for last DECADE
FAT CATS w/ Wall St collusion exploited The AGE of EASY MONEY
Via non supervised by Fed Reserve of “Shadow Banks” ie Citadel,
Susquehanna Investment Group ETC: SPOOFING, ALGO’s uneven
Playing Field for investors: Payment for Order Flow then milliseconds
Front Running ALL!
MUST VIEW
https://www.pbs.org/wgbh/frontline/documentary/age-of-easy-money/
SEC Gary Gensler ~90-95% of retail orders are not processed through the lit exchange..
https://t.co/rRst29wMYY https://t.co/qHeNt53sbI
BUY NOW or CRY Later: CrashOverRide
For last 4 yrs only allowed ONE daily NWBO post for INFINITY
DIFFERENCE
Before SWAT TEAM arrived 18 mos ago:
Summation only see full text.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=124101297
——————————————————————
Those supposed longs still SKEPTICAL, even at this ultra late stage on CEO lLinda Powers managerial PROWESS require yearS of personal consultation services which were unprofessionally addressed here.
FROM THRICE near ASHES to The PHOENIX ( posted since 2019!)
For last 4 years restricted to ONE post daily for INFINITY
DIFFERENT STROKES for DIFFERENT FOLKS
Citadel/Ken Griffin move to FLA re SPOOFING
CITADEL conflict of Interests as BOTH a TITAN Mkt Maker & Hedge Fund
MASSIVE Fails to Deliver (FTD's: NAKED Shorts)) on it's Balance Sheet reported by many.
Perhaps ALL those NAKED SHORTERS ALL 7 defendants in SPOOFING Federal suit went OVERBOARD to create more market mayhem PRE 2022 for what we have seen.
Awaiting Laura Posen April 10 AMENDED SPOOFING Federal suit: ie:
Continuing SPOOFING by defendants since Dec filing, include AFRAUDstein etc.
Influx of wealthy 2 FLA :
1)4 avoiding Winters for AGES!
2)4 TAX reasons(1 of 7 States having NO State Income Taxes!)
3)& the below reason 4 OJ Simpson types since 1990s.
Virtu Financial as 1 of 7 SPOOFING trial defendants , has it's owner also owning FLA Panthers.
Ken Griffin: Curious why after the pre 2021 Nugget real estate purchases in Chic/NY why so late 2 FLA: Chicago has always had a notorious reputation: Al Cappone & crime/murder rates.
@InvestorTurf #citadel #SPOOFING $NWBO
— maverick_1 (@maveric92283613) April 1, 2023
Influx of wealthy 2 FLA :
4 avoiding Winters then
4 TAX reasons & the below reason 4 OJ Simpson types in '90s.
Ken Griffin: Curious why after the pre 2021 Nugget real estate purchases in Chic/NY why so late 2 FLA https://t.co/PQzG6Zs2Ns
Bill Gates reTech Investing: 90% FAIL:Vaccines much harder!
#STOCKS #DISRUPTOR #CANCER $AAPL $TSLA $AMZN $NWBO #SPOOFING #CITADEL @InvestorTurf
— maverick_1 (@maveric92283613) March 31, 2023
Bill Gates on TECH 90% FAIL.
A new vaccine, as hard as discovering the next tech unicorn. (Vaccines much harder)https://t.co/RpM58TpU3vhttps://t.co/7VOwAgp6Gyhttps://t.co/uZK5NwD4fY
Bases are LOADED now that The New Era & how it may unfold has been depicted based on covering most all the variables & contigencies by many SWAT teams in last 18 mos to begin cleaning that pre-existing SWAMP via iHub, Twitter(esp @InvestorTurf!), Reddit.
Laura Posen of Cohen Milstein HAS generated good relations with both DOJ & SEC in the last decade.
Overnight bolt:
Roman516:
Keytruda SINCE 2014 to ‘16!: Cognitive DISSONANCE or DEMENTIA
NOV
2016
NW Bio Announces Phase II Clinical Trial Program Combining DCVax®-L and Pembrolizumab (Keytruda®) for Colorectal Cancer
Can eyes revived after death open the door to advances for age-related macular degeneration, glaucoma and other major causes of blindness? The Future of Everything looks at a new leap in efforts to restore lost vision.
https://www.wsj.com/articles/a-spark-of-life-after-death-points-to-new-hope-for-blindness-11662303872
Can eyes revived after death open the door to advances for age-related macular degeneration, glaucoma and other major causes of blindness? The Future of Everything looks at a new leap in efforts to restore lost vision.
https://www.wsj.com/articles/a-spark-of-life-after-death-points-to-new-hope-for-blindness-11662303872
A New Shot at Using Fish Oil - WSJ
https://www.wsj.com/articles/a-new-shot-at-using-fish-oil-11662385576
UNRAVELLING for EPIC U turn: Chronology
#STOCKS #DISRUPTOR #CANCER $TSLA $AMZN $NWBO #SPOOFING #CITADEL @InvestorTurf
— maverick_1 (@maveric92283613) March 28, 2023
re UK MHRA
BP’s w/patent cliffs looming ,unsuccessful in CHECKPOINT INHIBITOR trials(response rates<20% vs 60%!)
DealS w/upfront cash/milestone payments/%royalty
4 Uplisting & Instl Interest
Saw '15 Duke GBM: update?
Google search depicts GBM today:
People also ask
What is the best hospital for glioblastoma?
MD Anderson is #1 in Cancer Care
Glioblastoma is the most common and aggressive primary brain tumor in adults.
https://www.mdanderson.org › glio...
Glioblastoma | MD Anderson Cancer Center
What is the best treatment for glioblastoma in the world?
Radiation therapy for glioblastoma
Radiation therapy uses focused, high-energy beams to kill tumors or tumor sections that cannot be removed with surgery. MD Anderson offers the most advanced radiation therapy techniques in the world.
https://www.mdanderson.org › glio...
Glioblastoma | MD Anderson Cancer Center
Bottom of BIG pile::
What is the new breakthrough for glioblastoma?
In Rhode Island, scientists at Lifespan Cancer Institute said they've developed a vaccine that could extend the lives of glioblastoma patients. Researchers said in the Phase III trial, newly diagnosed patients treated with the vaccine survived for a median of 22.4 months from surgery and five-year survival was 13%.Feb 1, 2023
https://abc7ny.com › glioblastoma-...
Scientists across country make headway in fight against ...
Someone post FDA update on Duke's Polio Antivirius GBM trials.
DIFFERENT STROKES for DIFFERENT FOLKS
Rocket Ship LAUNCHED
Behind the curtain at some point is EW Healthcare Ptnrs Evis Hursever who for many years with her background & experience for over a decade got her firm to do a Mgnt Led Buyout, all the way to $875 mln Cash Sale of Cognate BioSciences to NYSE Charles River Labs!
60 posts after Bright Boy's what is FTD?
FAILS to DELIVER: re Shorts/NAKED Shorts !
Invariably I have & do get the last laugh having been on here since mid 2014 thru this EPIC that caught 99% flat footed or in consternation..
DIFFERENT STROKES for DIFFERENT FOLKS
Lend Out NWBO shs ??
BEST to contact ALL the following PROFESSIONALS vs Who can you TRUST: Those who are deeply immersed for pros & Cons BEFORE doing anything:.
1)NWBO David Innes; LES GOLDMAN
2)GNS CEO Roger Hamilton
3)Wes Christian law firm
BTW: Brokerage firms whether Fidelity or Schwab ETC will have THEIR Pecuniary interests above yours.... whereas the above see ALL the angles
Since exchanging with AlphaPuppy & Photonic re 2019 ASCO, I am allowed ONE daily post for INFINITY, so this one merits!
DIFFERENT STROKES for DIFFERENT FOLKS
EW HC + NWBO like
ORCL's Ellison $2011: to Elon Musk:
TSLA Giga#1 ...,SpaceX
IMHO:
Too few have known that in 2011 Elon MUSK needed to raise $180 mln in 12 hrs
Larry Ellison! I've known about since 1983!
Ellison has been a good friend to Elon Musk: Ellison has been TSLA largest shareholder.
Well IMHO EW Healthcare which I've known about since 1987 will be KEY!
AND Winning SPOOFING trial
BIG Lottery Winner for NWBO
Intrepid, Indefatigable Supreme Navigator CEO Linda Powers to The PHOENIX despite Multi Front Wars!
$ NWBO A RELEVANT ANALOGY IMHO:Too few have known that in 2011 Elon MUSK needed to raise $180 mln in 12 hrs: Larry Ellison! I've known about since 1983!
— maverick_1 (@maveric92283613) March 12, 2023
Well IMHO EW Healthcare which I've known about since 1987 will be KEY!
BIG NEW Bank Rules so NO Banks go under & CAN LOAN vs losses: Run on Banks
#FederalReserve $SVB $NWBO
— maverick_1 (@maveric92283613) March 13, 2023
Countering Hysteria
NEW Bk Program: loans 2 banks, crdt uns,& fin instn 4 1 yr. Collateralized by Govt backed secs: FACE Value!(KEY)vs Mkt(Loss!)so banks CAN LEND! vs Recrshp
Yrend '22 FDIC : $620 billion unrealized losses, https://t.co/piWXlzWEwq
The Danish Dude is GONE
Twitter:
WRAPUP: 4th FEMALE PHENOM to Join IMHO
Reply Order
Thank you Captain Obvious: 3x),HSpooner, Chiugay, GoodguyBill, Lorie3168, Marzan
Two posters voting for SAME:
A)1)Jill Biden:
Captain Obvious & Marzan
B)2) Dame June Raine DBE
CEO of UK’s MHRA
GoodguyBill & Lorie3168
Cathy Woods Hd of ARK Invest a Mutual Fund complex:
ChiuGray
Tamara Kondic
Donahue Advisory Services
HSpooner
Clues cited:
1) Well the Female TRIO will, IMHO be joined by a FOURTH who will be, IMHO, also granted newly authorized shares & instrumental in jettisoning NWBO marketplace visibility (despite OTC Pink Sheet status) upon CDMO’s Advent expected MIA … MRHA!
Meaning: A) the female’s firm has the demonstrated $ wherewithal to at least get NWBO financials in order to meet NASDAQ listing requirementS:
TALL ORDER!
B) The 4th Female PHENOM has the “clout” among her firm’s Board of Directors or Managing Directors to deploy a significant monetary sum and can, if needed round up a finance network syndicate foe deal completion:
ALL in exchange for newly authorized NWBO shares.
2) as NWBO’s new LT financier IMHO
ie replacing disgraced Neil Woodford!
3) This NEW fourth Female PHENOM did NOT come out of the blue!
Implying there IS already an established financial relationship with NWBO
YES all the women proffered by our named posters above: “did NOT come out of the blue”
The three female phenoms NOW are:
1) NWBO CEO Linda Powers
2) UCLA’s Dr. Linda Liau
3) Cohen Milstein Partner Laura Posner
The 4th female phenom to join IMHO has been “a mover and shaker” & RAIN MAKER.
1)has made money for her firm a few times with NWBO
2)was the mastermind and convinced her firm to be the major equity holder and created a finance network syndicate for supplemented funding.
MY take on:
2 Citing for Jill Biden:
credentialed First Lady to Pres. Joe Biden who lost his beloved son Beau Biden to GBM should be, as well as his advisors in a position to know GBM & NWBO
BUT does Pres. Joe Biden have the exclusive Power of his Office to BOTH Fund NWBO & receive newly authorized NWBO shares??
IMHO Same applies for Federal Agencies
AND of course I have NO knowledge/let alone insights to this Bureaucratic labyrinth
2 Citing for CEO of UK's MHRA's:
Dame June Raine DBE
Impressive credentials and achievements
I would apply the same commentary indicated above for Jill/Pres. Joe Biden as this is also the UK!
1 for ARK Invest
Cathy Woods:
Thanks ChiuGray for your Over the Top supportive narrative you voluntarily indicated for your choice.
Especially got a big chuckle for your:
Pending 4th FEMALE Phenom as NWBO new LT financier IMHO
IMHO this firm has ALL the necessary ingredients to vault NWBO to add $ for newly authorized NWBO shares to NASDAQ qualify UPLISTING: Which should mitigate "holding the shares down", begin the process of upward valuation, from the 6 years of market manipulation tyranny of OTC Pink Sheets as well as avoiding a Reverse Split (which is what I have consistently posted as my reading between the lines and into CEO Linda Powers mindset which few if any have done correctly given the SILENCE since 2016) along with AVOIDING the timeline uncertainties of:
1) waiting for a reasonable $SPOOFING settlement; or
2)jury trial; or
3)that of assessment damages....
ALL of which must be approved by the court (Maverick_1 is NOT a lawyer! so I could stand corrected.) ..... the duration is unknown so I believe that inscrutable CEO Linda Powers other clandestine "nuclear weapon" is with The FOURTH FEMALE PHENOM as Time is Money along with her other unveiled cards that are set up for a HUGE TSUNAMI for shorts/naked shorts
ALL of this is IMHO before ANY Big Pharma Board of Directors approves taking an equity stake in NWBO.
A licensing, joint venture in any clinical trial IE: Checkpoint Inhibitors is separate and
distinct from this discussion.
I have stated that :
"Every BIG Pharma needs NWBO".
The entirety of this authored thread below & replies is a MUST READ as it is likely few know of it..... that expounds on it.... which no one else has done PERIOD:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151899702
Special Note:
Special thanks to Bright Boy's post: People! Listen UP:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171325611
that generated a fast Brainstorm:
My first & only hunch took less than 30 minutes for me to validate from many angles. So I did my vetting!
AND I let it gestate and tried to punch holes as my own devil's advocate.
Nothing is assured but the likelihood is 75+% IMHO.
So if you are so inclined you might spend the next 30 hours till 4pm Tues mkt close to reply on this thread your sleuthing as to who is
The FOURTH FEM PHENOM that will vault NWBO at this critical juncture.
Hopefully ChiuGrey you see that the above is a vital key strategic priority over all else.
AND tomorrow Tuesday at 9PM EST I will do the unveiling.
DIFFERENT STROKES for DIFFERENT FOLKS
Anyone find this COINCIDENCE: TRIO of “legendary women”: to be joined by a FOURTH IMHO
Women understand women and can multitask :scientifically proven courtesy of Dr. Daniel Amen doing 50K Brain SCANS versus men!
First & foremost:
VISIONARY Against ALL the UNSURMOUNTABLE OBSTACLES, always going the extra mile, avoided THRICE being burnt to a crisp to now
The PHOENIX:
NWBO’s CEO Linda Powers
In a different vein but as equally astounding the perfecto of DC VAX L:
UCLA’s Dr. Linda Liau
Cohen Milstein Sellers & Toll PLLC’s NYC based Laura Posner: lead attorney filing Federal Suit on NWBO MKT price MANIPULATION via ILLEGAL SPOOFING.
https://profiles.superlawyers.com/new-york/new-york/lawyer/laura-h-posner/77187fb9-d471-4edd-a06d-7126e8eb392e.html
No one can predict the outcome of the litigation process.
My recent post still stands:
Notification~ a DECADE ago:
WaveLengthy: been a fan since 2017 & still just 3???
A BEACON on THE EPIC STRUGGLE : Learning Every Trade
NWBO ‘s turn: WHEN? as yet ANOTHER Naked Short Co BEGINS HARVESTING!
Unlike those who deflect for their partial obfuscuscating & deflecting logic and narrative which has since mid 2014 been par for this message board in this EPIC re Complete Naked Short Arsenal against Manipulators & Wall St Titans.
AND it depends on whether CEO Linda Powers wants to devote more energy & resources in her yet unexposed hand on her already overflowing plate of PRIORITIES
GNS was NOT Pumping!!
GNS Up to $3.50 ( $5.19/high today) from 40 CT’s n 3 days!
So far volume is 165 million shares , yesterday the same, when there is only ~25 mln shr’s outstanding!
CEO did the raise primarily to use it as their weapon against the Manipulation Naked Shorts forces as a NYSE co which CRASHED from $66 to under 40 cents in less than 9 months when operating results IMPROVED
Using a Special Dividend WORKS
IF people would do COMPLETE Due Diligence versus mouthing off such statements as:
ISSUING A SPECIAL DIVIDEND & the NINE Others don’t work from Crash Override……
VERSUS coming from a CEO!!
AND that of Sentiments “ he did not mentioned hiring the specialist firm in uncovering NAKED SHORTS, when CEO Roger Hamilton DID hire months ago
ALL of what GNS CEO Roger Hamilton produced this in under TWO DAYS leaving the above posted comments too fast and loose!
Seen it here IN BUCKETS since mid 2014!
There is a science to dealing successfully with NAKED SHORTS!
EACH CEO decides based on armies of hired advisors and even specialists to find the RIGHT DEPLOYMENT Mechanism versus retail individuals PERIOD!
A MAVEN, BIO9999 on FDA Oncology Protocol &: Histronics in ONE concise post (vs GrandStanding without LINKS!)
Wes Christian Law firm has been engaged since November 2022 by GNS CEO 54 yr old Roger James Hamilton ( do a Linked In or Google) whose shares CRATERED from Mid April 2022 high of $36 to below 30 CT’s:
Re: 7:24a ET 1/4/2023 - Dow Jones
Marzan's ever expanding minions & many other drove of NWBO posters, many of whom I interacted on iHub AMRN's message board are here.
It began when AMRN zoomed from $1 to high teens and many of AMRN posters
have thru their own Due Diligence migrated here over many years ago.
NWBO needed in 2017 period a fresh INFUSION of NEW investors.
NWBO was on life support for many years beginning with the Koneyama trial (UCSF was at the center of this vs the illogical conclusion posted here).
Blood transfusions thru new investors were the order of the day versus the nonsense of bad & forth non constructive short messages.
They likely control easily 40+ million shares AND some have participated in NWBO's direct private placements on an accredited investor status.
So what began from one of Marzan's acknowledgements ...........
Real time VALIDATION of Biotech Financing Scene:
MEDIA PR's beginning ROLL OUT
From RIHT LifeSpan Dr. Tom Stevens (covered by NYC Fox 5, Providence Chanel 11, Providence Business News ETC.)
to ALL 69 other co-authors of JAMA Oncology Review Nov 2022 as DStock07734 re https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170889764
& other neuro sleuths open a new era on this board!
IMHO one of CEO Linda Powers unfolding procession of POWER PLAYS
Today! Laser focused BIG BAZOOKA Wes Christian joining on Contigency Fee basis!! Is working with Coffer Black (NWBO Bd Member & CIA!!)
His primary focus in the last 11 years has been suing Wall Street for fraud.
“We take cases on a contingency basis. It costs even at our level $7 million to prosecute a case. We need a high damage model. Typically, we represent the company and its largest shareholders.” He explained, “We need a damage model of at least $100 million. The issuer has the largest damages.”
”Christian said the brokers were lending cash account shares, which were not leveraged with borrowed funds, were required to be segregated from margin accounts and under SEC rules “can’t be touched, but they are being used.”
Only since mid 2019, 3+ months AFTER the NWBO Annual Shareholders meeting in FEBRUARY did anyone pay ANY attention to CEO Linda Powers LENGTHY remarks (re Share Price & Naked Shorting & CASH Accounts!vs margin accounts). BUT everyone here led by high profile grandstanding posters paid attention ONLY to the science! Ignoring the marketplace’s BIG COMPOSITE PICTURE when your Net Worth has cratered to the bottom of Grand Canyon has been fatal or near fatal for too many: why we have a chronic surplus of Pissers & Moaners who are “novice to neophyte investors” pounced on by big, deep, powerful and exceptionally well connected in perpetuating their “MIGHT is right” re IE Citadel; Susquehanna Investment Group ETC.
AND I did have a lengthy post here many, many years ago of how by happenstance while riding Metro North back to Greenwich, CT how I met the CEO of Pershing & Co the largest Clearing firm for then Donaldson , Lufkin, & Jenrette DLJ: founders were Yale graduates
The Stock Loan Dept of Prime Brokers is one of most consistently profitable and non cyclical and growing profit centers of any Wall St finance co’s PROFITABILITY.
https://www.pershing.com/what-we-provide/prime-services/securities-lending
Pershing still is a major factor, now under the umbrella of Bank of New York, Mellon.
AND
You might find these interesting:
The MEDIA & Social Media DeepCapture.com's KEY Chapters
A Needed REFRESHER course that I pointed out SINCE 2014-2015!
The BIGGER picture I promulgated since 2014 that too few ever gave the proper recognition: even Larry Smith whom I met as he was Director of Research at Smith Barney and first analyst to recommend Amgen! and now the online Smith on Stocks only belatedly acknowledged in 2019 while Larry Smith has been DEEPLY immersed in Biotechs since the 1980's!
IE A FOREIGN language (ONLY in last year! has it become The MARQUE!) versus grandstanding high profile posters pre occupation on The Science ....
Chapter 2 – The Journalists Tried to Be Players But Became Pawns
Over the last fifteen years the standards of financial journalism have been eroded by a group of reporters who have tried to appear as players, but have become pawns. A significant fraction of the journalists on the Wall Street beat have become shills of a handful of hedge funds
Chapters 8 and 9: The Cover-Up
Chapter 8 – The Deep Capture Campaign
The financial media are incapable of bringing a critical mindset to this issue because of their too-cozy relationship with Wall Street several financial journalists actually seem to be engaged in blue-smoke-and-mirror attempts to obfuscate issues on behalf of the financial elites who turn up wherever this crime is occurring). As a result, the crack in our financial system appears to be reaching catastrophic proportions.
Chapter 9 – The Hijacking of Social Media
Within “social media” (blogs, message boards, and wikis) evidence for the preceding points has been pieced together, but there is a campaign to hijack the social media discourse, organized by the same people who are profiting from the crime
https://www.deepcapture.com/introduction-to-the-deep-capture-analysis/
For The GREATER GOOD
versus Powerful Capitalist (why the world is IMPLODING for last two decades!)
Been saying this for too many years: AND was NOT surprised by my early documented elsewhere early warnings of STAGFLATION since late 2021!
and the world's central bankers way way behind the curve! Re BOTH Inflation AND Raising Interest Rates A prestigious Washington DC think tank said that when the US Inflation rate gets to the Fed's 2% Inflation Rate.... US Unemployment Rate will be 7.5%!
In Fast Paced Emerging BioTech's best to be UNinvested versus the HIGH cost of learning on the job which 99% have experienced here.... or in other emerging biotechs.
In my five years thru 2019 here I have found that making timely critical investment/judgemental assessments, is totally absent! and explains why oil does not mix with water or can't teach an old dog new tricks.
Making timely and correct investment judgements is the be all and end all! of INVESTING: A mantra I've practiced in all my life long undertakings.
Now after the tortuous near death experiences since 2015 NWBO should be a Harvard Business School case study!
Nevertheless:
THIS is still a PROCESS & The precursor of The Beginnings of a New Era for NWBO!
From more than TWICE near ASHES to The PHOENIX where
The Legacies of Two Femme PHENOMS against Two Decades of INSURMOUNTABLES will be heralded for The Ages!
For the last 2+ years…Since I am only allowed one NWBO post per day along with my experience here since 2014, unlikely to expand on the time consuming complexities of the above, let alone the back and forth (2014- 2019) on iHub
That's why:
DIFFERENT STROKES FOR DIFFERENT FOLKS
Susquehanna International Group ie SIG (a Defendant on Massive Price Manipulation)
No one here understood what I posted since 2014….PERIOD…
Just focus on the Science with an EXCLUSION to ALL else.
Only recently since May DEBACLE at NYAS have most paid any attention.
So why do I even bother??
Here is the latest info on this PRIVATE company holdings
INFO
Size ($ in 1000's)
At 09/30/2022: $386,869,957 THATS $387 BILLION!
At 06/30/2022: $404,340,209
Combined Holding Report Includes:
SUSQUEHANNA INTERNATIONAL GROUP LLP
SUSQUEHANNA INVESTMENT GROUP
SUSQUEHANNA SECURITIES LLC
CAPITAL VENTURES INTERNATIONAL
SUSQUEHANNA ADVISORS GROUP INC.
CVI Opportunities Fund I LLLP
G1 EXECUTION SERVICES LLC
Darby Financial Products
Susquehanna International Group LLP holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Susquehanna International Group LLP 13F filings. Link to 13F filings: SEC filings
https://www.holdingschannel.com/13f/susquehanna-international-group-llp-top-holdings/
https://en.wikipedia.org/wiki/Susquehanna_International_Group
In 8 years SIG’’s holding were up NINE FOLD:
While NWBO went from ~$ 9+ To ~$1.
FWIW: BIG LT Chart Change
GOLDEN CROSS!
BUT May mean nothing re my last post:
Unless someone has BETTER than Level 2 OTC screens, not likely you will get an answer: Screenshots posted to validate vs heresay!.
The DARK, DEEP, POWERFUL, ENTRENCHED & RELENTLESS FORCES which I have worked with many decades ago includes even High Profile Media (excluding AF) which for many years HERE & elsewhere have been SADLY for too MANY YEARS put on tertiary sideshow status since 2015! focusing solely on the clinical DC VAX L TRIAL which obviously no one here or elsewhere sensed it's extenuation!
From what time I have devoted to it, there has been IMHO a.....
DRAMATIC attenuation from PRE Federal Filing of Manipulating to AFTER .
BUT OTCN has been a noted leader POST Federal Filing to possibly offset that of cited:CDEL, CSTI, ETC.
THEY WILL Fight ( RUTHLESSLY) to the BITTER END IMHO because they have made TONS of $ on the BEAR Market which few have cited since early 2022.
DIFFERENT STROKES for DIFFERENT FOLKS
A golden cross is a technical chart pattern indicating the potential for a major rally. The golden cross appears on a chart when a stock's short-term moving average crosses above its long-term moving average. The golden cross can be contrasted with a death cross indicating a bearish price movement.
Unless someone has BETTER than Level 2 OTC screens, not likely you will get an answer: Screenshots posted to validate vs heresay!.
The DARK, DEEP, POWERFUL, ENTRENCHED & RELENTLESS FORCES which I have worked with many decades ago includes even High Profile Media (excluding AF) which for many years HERE & elsewhere have been SADLY for too MANY YEARS put on tertiary sideshow status since 2015! focusing solely on the clinical DC VAX L TRIAL which obviously no one here or elsewhere sensed it's extenuation!
From what time I have devoted to it, there has been IMHO a.....
DRAMATIC attenuation from PRE Federal Filing of Manipulating to AFTER .
BUT OTCN has been a noted leader POST Federal Filing to possibly offset that of cited:CDEL, CSTI, ETC.
THEY WILL Fight to the BITTER END IMHO because they have made TONS of $ on the BEAR Market
DIFFERENT STROKES for DIFFERENT FOLKS
I’d bet BSB would know their “handles.”
How about this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=141659228
Invariably, I DO get the LAST Laugh
DIFFERENT STROKES for DIFFERENT FOLKS
AF just put out another hit piece
(BIG DAH!)
DITTO done since 2014 for those comrades.....gangs that ply ALL message boards ... SEE DeepCapture.com especially the Dendreon section NONE of which since 2014 was ever acknowledged here PERIOD...
I directly witnessed firsthand how Wall Street really works especially in situations like this (Institutions BAILED NWBO at $7; I Bailed at $11+; Neil Woodford a 10% holder at $6.84 avg per share cost tried to fool everyone except moi!) since the 1980's as both:
1) an analyst at top tier Wall Street firms and dealt with high profile HEDGE FUNDS with a Short/Long orientation.
2) Discretionary Mooney Manager
AND
3)DESPITE the years here from 2014 till present FACED all the slings and arrows here! from most every imaginable viewpoint PERIOD: from even grandstanders here who got it wrong too many times to even posters on iHub Biotech Values message board.
When it's Oil AND Water:
Why BOTHER!
I even posted that despite a BEAR Market, the Stock Loan Departments of major Wall Street firms make a BIG Bundle of $ Lending Out retail accounts margined hypotheticated shares to SHORT HEDGE FUNDS
I am the least surprised of what has transpired since 2015 in this LONG EPIC SAGA!
UNLESS there emerges short term NWBO Strategic Partnerships and Deals of REAL substance to right the NWBO ship that will redress the IMBALANCE to date, expect more of the same!..........
by the Deep, Powerful DARK Nefarious forces that has been a growing force on Capital Markets PERIOD.
Barring the above.....
Down another road till one of 4 Regulatory Approvals for DCVAX L !
DIFFERENT STROKES for DIFFERENT FOLKS
JAMA Oncology
https://www.dr-bala.net/NWBO/jamaoncology_liau_2022.pdf
Would not be surprised with the ensuing
Partnership deals awaits.
1. Joint clinicals FUNDED by partner.
Many thousands of Checkpoint Inhibitor trials (CPI) have LOW response rates when there is a much higher response rate with NWBO’s technology platform
2) CASH Infusion
3) Significant NWBO EQUITY Interest above Mkt shr price to give NWBO Marquee status from much malignant innuendos that have been out to bury & bankrupt by so called “journalist”.
With the peer reviewed journal article
NWBO moves into a new life chapter.
Out of the Deep powerful DARK NEFARIOUS Wall St. forces and into the REAL world of complementing Big Pharma!
DIFFERENT STROKES for DIFFERENT FOLKS